Table 1.

Vaccine formulations, number of immunizations, and protection in buffaloes.

Group	Vaccine formulations	No. of immunizations	Inoculum strainc	No. of buffaloes without clinical sign/total (%)
1	100 µg each rOmpH + CpG ODN 10 µga	6	M-1404	4/6 (66.67)
2	200 µg each rOmpH + CpG ODN 10 µga	6		6/6 (100)
3	Commercial haemorrhagic septicemia vaccineb	6		5/6 (83.33)
4	No vaccination	6		0/6 (0)d

^aIntranasal administration with 1.0 ml/dose. ^bIntramuscular administration with 1.0 ml/dose. ^cChallenge inoculum was 1 ml of PBS containing approximately 10³ CFU/ml. ^dThis group was terminated due to the clinical signs of buffaloes.